Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4609242 | 0.92 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2TSHRL3MBTL1LMNA | |
| SCHEMBL26739892 | 0.90 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2TSHRL3MBTL1LMNA | |
| SCHEMBL13864131 | 0.89 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2TSHRL3MBTL1LMNA | |
| SCHEMBL11030766 | 0.89 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2TSHRL3MBTL1LMNA | |
| SCHEMBL5163869 | 0.89 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2TSHRL3MBTL1LMNA | |
| SCHEMBL5159311 | 0.89 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2TSHRL3MBTL1LMNA | |
| SCHEMBL8017511 | 0.87 | — | — | |
| SCHEMBL28421935 | 0.85 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2TSHRL3MBTL1 | |
| SCHEMBL8130972 | 0.85 | — | — | |
| SCHEMBL19655527 | 0.85 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2TSHRL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112574339-B | Multi-element external electron donor composition for olefin polymerization, olefin polymerization catalyst comprising same, and olefin polymerization method | 中国石油天然气股份有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-112574339-A | Multi-element external electron donor composition for olefin polymerization, olefin polymerization catalyst comprising same, and olefin polymerization method | 中国石油天然气股份有限公司 | 2021-03-30 | — | — | CN | claimed |
| US-12281185-B2 | Anionic polymerization process and polymer production method | KURARAY CO., LTD. (JP) | 2025-04-22 | — | — | US | disclosed |
| EP-3845570-B1 | ANIONIC POLYMERIZATION PROCESS AND POLYMER PRODUCTION METHOD | KURARAY CO (JP) | 2024-10-09 | — | — | EP | disclosed |
| US-12037453-B2 | Aromatic polyethers containing a biosourced furan diol | ROQUETTE FRERES (FR) | 2024-07-16 | — | — | US | disclosed |
| CN-118221851-A | Catalyst for preparing ultra-high molecular weight polyethylene and preparation method thereof | 中国石油天然气股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-11845818-B2 | Active energy ray crosslinkable thermoplastic polymer and composition containing the same | KURARAY CO., LTD. (JP) | 2023-12-19 | — | — | US | disclosed |
| US-20230357134-A1 | AGENTS FOR USE IN THE TREATMENT OF AMYLOIDOSIS | UCL BUSINESS LTD (GB) | 2023-11-09 | — | — | US | disclosed |
| CN-113453898-B | Active energy ray-crosslinkable thermoplastic polymer and composition containing same | 株式会社可乐丽 | 2023-10-20 | — | — | CN | disclosed |
| EP-4056604-B1 | METHOD FOR PRODUCING COPOLYMER OF 1,3,7-OCTATRIENE AND STYRENE | KURARAY CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-3564280-B1 | COPOLYMER OF 1, 3, 7-OCTATRIENE AND STYRENE AND HYDRIDE THEREOF | KURARAY CO (JP) | 2023-07-26 | — | — | EP | disclosed |
| EP-1078942-A1 | Anionic polymerization process, and process for producing a polymer by the anionic polymerization process | KURARAY CO., LTD. (JP) | 2001-02-28 | — | — | EP | disclosed |
| EP-0690104-A2 | Dye preparation | BASF Aktiengesellschaft (DE) | 1996-01-03 | — | — | EP | disclosed |
| EP-0501167-B1 | Liquid dye preparations | BASF AG (DE) | 1995-07-05 | — | — | EP | disclosed |
| US-5205838-A | LIQUID DYE PREPARATIONS: BIS PHENYL-AZO-RESORCINOL IN SOLVENT FOR COLORED RIBBON OR BALL PEN INK | BASF AKTIENGESELLSCHAFT (DE) | 1993-04-27 | — | — | US | disclosed |
| EP-0501167-A1 | Liquid dye preparations | BASF Aktiengesellschaft (DE) | 1992-09-02 | — | — | EP | disclosed |
| US-5114932-A | Hyperosmolar oxyreplete hemosubstitute | RUNGE THOMAS M (US) | 1992-05-19 | — | — | US | disclosed |
| US-4477447-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | disclosed |
| US-3993581-A | WITH A PHOSPHOLIPID AS EMULSIFIER AND A FATTY ACID, ALKALI METAL SALT OR ITS MONOGLYCERIDE AS AN ADJUVANT | THE GREEN CROSS CORPORATION (JA) | 1976-11-23 | — | — | US | disclosed |
| US-3962439-A | PERFLUOROCARBON COMPOUNDS | THE GREEN CROSS CORPORATION (JA) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357134-A1 | AGENTS FOR USE IN THE TREATMENT OF AMYLOIDOSIS | TTR, C1R, APOB | ALDH1A1 1891/4885SMN1; SMN2 1033/4885TSHR 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.